BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34533198)

  • 21. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.
    Yu T; Liu L; Li J; Yan M; Lin H; Liu Y; Chu D; Tu H; Gu A; Yao M
    Oncotarget; 2015 Oct; 6(30):30239-50. PubMed ID: 26317552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
    Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
    Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhang W; Shao X
    Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
    Bu W; Luo T
    DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
    Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
    Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S; Ma Y; Hu X; Zheng Y; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rab11-FIP2 suppressed tumor growth via regulation of PGK1 ubiquitination in non-small cell lung cancer.
    Dong W; Li H; Wu X
    Biochem Biophys Res Commun; 2019 Jan; 508(1):60-65. PubMed ID: 30471866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
    Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
    Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA circ-PTEN elevates PTEN inhibiting the proliferation of non-small cell lung cancer cells.
    Wang Y; Wang Z; Lu J; Zhang H
    Hum Cell; 2021 Jul; 34(4):1174-1184. PubMed ID: 33821441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis.
    Xia S; Zhang Z
    Clinics (Sao Paulo); 2022; 77():100086. PubMed ID: 35917658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines.
    Akca H; Demiray A; Aslan M; Acikbas I; Tokgun O
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):539-44. PubMed ID: 22299584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and clinical significance of mTOR and PTEN in non-small cell lung cancer].
    Wang L; Xu S; Yue W; Zhao X; Zhang L; Wang Y
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):717-21. PubMed ID: 20673489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
    Han S; Roman J
    Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
    Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
    Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling.
    Dai L; Chen F; Zheng Y; Zhang D; Qian B; Ji H; Long F; Cretoiu D
    Front Biosci (Landmark Ed); 2019 Jun; 24(8):1426-1439. PubMed ID: 31136988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway.
    Meng W; Meng J; Jiang H; Feng X; Wei D; Ding Q
    Anal Cell Pathol (Amst); 2020; 2020():6021602. PubMed ID: 33354489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
    Gao X; Han H
    J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway.
    Mi S; Xiang G; Yuwen D; Gao J; Guo W; Wu X; Wu X; Sun Y; Su Y; Shen Y; Xu Q
    Toxicol Appl Pharmacol; 2016 Nov; 310():78-86. PubMed ID: 27639426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.